Silodosin
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Benign Prostatic Hyperplasia
Conditions
Benign Prostatic Hyperplasia
Trial Timeline
May 1, 2011 โ Aug 1, 2013
NCT ID
NCT01757769About Silodosin
Silodosin is a approved stage product being developed by Recordati for Benign Prostatic Hyperplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT01757769. Target conditions include Benign Prostatic Hyperplasia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01757769 | Approved | Completed |
Competing Products
20 competing products in Benign Prostatic Hyperplasia